+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Triamcinolone"

Keloids Treatment Market Report 2025 - Product Thumbnail Image

Keloids Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Anti-Inflammatory Therapeutics Market Report 2025 - Product Thumbnail Image

Anti-Inflammatory Therapeutics Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Hypertrophic and Keloid Scar Treatment Market Report 2025 - Product Thumbnail Image

Hypertrophic and Keloid Scar Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Sinusitis Pipeline Insight Analysis Report - Product Thumbnail Image

Sinusitis Pipeline Insight Analysis Report

  • Drug Pipelines
  • August 2024
  • 150 Pages
  • Global
From
From
From
From
From
From
From
  • 16 Results (Page 1 of 1)
Loading Indicator

Triamcinolone is a corticosteroid used to treat respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. It is used to reduce inflammation in the airways, which can help reduce symptoms such as wheezing, coughing, and shortness of breath. It is available in both oral and inhaled forms, and is often used in combination with other medications. Triamcinolone is also used to treat allergic rhinitis, which is an inflammation of the nasal passages caused by allergies. The triamcinolone market is a growing segment of the respiratory drugs market. It is used to treat a variety of respiratory conditions, and is often prescribed in combination with other medications. The market is expected to continue to grow as more people are diagnosed with respiratory diseases, and as new treatments become available. Some companies in the triamcinolone market include GlaxoSmithKline, Merck, Pfizer, and Sanofi. Show Less Read more